메뉴 건너뛰기




Volumn 156, Issue 2, 2017, Pages 285-288

Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014

Author keywords

FDA; medical device; otolaryngology; premarket approval

Indexed keywords

CLINICAL OUTCOME; COCHLEA PROSTHESIS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DEVICE APPROVAL; DEVICE SAFETY; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; INJECTABLE IMPLANT; MARKETING; OTOLARYNGOLOGIST; OTORHINOLARYNGOLOGY EQUIPMENT; RISK BENEFIT ANALYSIS; TREATMENT INDICATION; CLINICAL TRIAL (TOPIC); DEVICES; FOOD AND DRUG ADMINISTRATION; OTORHINOLARYNGOLOGY; RISK ASSESSMENT; UNITED STATES;

EID: 85011556259     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599816684094     Document Type: Conference Paper
Times cited : (5)

References (26)
  • 2
    • 85011584503 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed June 29, 2016
    • US Food and Drug Administration. Premarket approval. http://www.fda.gov/Medicaldevices/Deviceregulationandguidance/Howtomarketyourdevice/Premarketsubmissions/Premarketapprovalpma/Default.Htm. Published 2016. Accessed June 29, 2016.
    • (2016) Premarket Approval
  • 5
    • 84868313703 scopus 로고    scopus 로고
    • Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval
    • Chen CE, Dhruva SS, Redberg RF,. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. JAMA. 2012; 308: 1740-1742.
    • (2012) JAMA , vol.308 , pp. 1740-1742
    • Chen, C.E.1    Dhruva, S.S.2    Redberg, R.F.3
  • 6
    • 73949084847 scopus 로고    scopus 로고
    • Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices
    • Dhruva SS, Bero LA, Redberg RF,. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. JAMA. 2009; 302: 2679-2685.
    • (2009) JAMA , vol.302 , pp. 2679-2685
    • Dhruva, S.S.1    Bero, L.A.2    Redberg, R.F.3
  • 7
    • 84931260898 scopus 로고    scopus 로고
    • Pivotal clinical trials of novel ophthalmic drugs and medical devices: Retrospective observational study, 2002-2012
    • Hwang J, Hwang TJ, Ciolino JB,. Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002-2012. BMJ Open. 2015; 5: e007987.
    • (2015) BMJ Open , vol.5 , pp. e007987
    • Hwang, J.1    Hwang, T.J.2    Ciolino, J.B.3
  • 8
    • 84899845894 scopus 로고    scopus 로고
    • Postmarketing trials and pediatric device approvals
    • Hwang TJ, Kesselheim AS, Bourgeois FT,. Postmarketing trials and pediatric device approvals. Pediatrics. 2014; 133: e1197-e1202.
    • (2014) Pediatrics , vol.133 , pp. e1197-e1202
    • Hwang, T.J.1    Kesselheim, A.S.2    Bourgeois, F.T.3
  • 10
    • 84963930653 scopus 로고    scopus 로고
    • Physicians' knowledge about FDA approval standards and perceptions of the "breakthrough therapy" designation
    • Kesselheim AS, Woloshin S, Eddings W, Franklin JM, Ross KM, Schwartz LM,. Physicians' knowledge about FDA approval standards and perceptions of the "breakthrough therapy" designation. JAMA. 2016; 315: 1516-1518.
    • (2016) JAMA , vol.315 , pp. 1516-1518
    • Kesselheim, A.S.1    Woloshin, S.2    Eddings, W.3    Franklin, J.M.4    Ross, K.M.5    Schwartz, L.M.6
  • 11
    • 84939155744 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed June 29, 2016
    • US Food and Drug Administration. Premarket approval (PMA) database. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm. Published 2015. Accessed June 29, 2016.
    • (2015) Premarket Approval (PMA) Database
  • 12
    • 84940999506 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed June 29, 2016
    • US Food and Drug Administration. Product code classification files. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051668.htm. Published 2014. Accessed June 29, 2016.
    • (2014) Product Code Classification Files
  • 13
    • 70349914121 scopus 로고    scopus 로고
    • Using effectiveness and cost-effectiveness to make drug coverage decisions: A comparison of Britain, Australia, and Canada
    • Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ,. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA. 2009; 302: 1437-1443.
    • (2009) JAMA , vol.302 , pp. 1437-1443
    • Clement, F.M.1    Harris, A.2    Li, J.J.3    Yong, K.4    Lee, K.M.5    Manns, B.J.6
  • 14
    • 84892726671 scopus 로고    scopus 로고
    • Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012
    • Downing NS, Aminawung JA, Shah ND, Krumholz HM, Ross JS,. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012. JAMA. 2014; 311: 368-377.
    • (2014) JAMA , vol.311 , pp. 368-377
    • Downing, N.S.1    Aminawung, J.A.2    Shah, N.D.3    Krumholz, H.M.4    Ross, J.S.5
  • 15
    • 84941009742 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed June 29, 2016
    • US Food and Drug Administration. Post-approval studies database. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma-pas.cfm. Published 2015. Accessed June 29, 2016.
    • (2015) Post-approval Studies Database
  • 16
    • 84872082045 scopus 로고    scopus 로고
    • The 510(k) ancestry of a metal-on-metal hip implant
    • Ardaugh BM, Graves SE, Redberg RF,. The 510(k) ancestry of a metal-on-metal hip implant. N Engl J Med. 2013; 368: 97-100.
    • (2013) N Engl J Med , vol.368 , pp. 97-100
    • Ardaugh, B.M.1    Graves, S.E.2    Redberg, R.F.3
  • 17
    • 84893129008 scopus 로고    scopus 로고
    • Presumed safe no more: Lessons from the Wingspan saga on regulation of devices
    • Gartenberg AJ, Peleg A, Dhruva SS, Redberg RF,. Presumed safe no more: lessons from the Wingspan saga on regulation of devices. BMJ. 2014; 348: g93.
    • (2014) BMJ , vol.348 , pp. g93
    • Gartenberg, A.J.1    Peleg, A.2    Dhruva, S.S.3    Redberg, R.F.4
  • 18
    • 40449140715 scopus 로고    scopus 로고
    • Semper fidelis - Consumer protection for patients with implanted medical devices
    • Maisel WH,. Semper fidelis-consumer protection for patients with implanted medical devices. N Engl J Med. 2008; 358: 985-987.
    • (2008) N Engl J Med , vol.358 , pp. 985-987
    • Maisel, W.H.1
  • 19
    • 80052834654 scopus 로고    scopus 로고
    • Stenting versus aggressive medical therapy for intracranial arterial stenosis
    • Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011; 365: 993-1003.
    • (2011) N Engl J Med , vol.365 , pp. 993-1003
    • Chimowitz, M.I.1    Lynn, M.J.2    Derdeyn, C.P.3
  • 20
    • 85011593943 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed October 23, 2016
    • US Food and Drug Administration. Medical device recalls. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm. Published 2016. Accessed October 23, 2016.
    • (2016) Medical Device Recalls
  • 21
    • 84963502461 scopus 로고    scopus 로고
    • Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 US Food and Drug Administration approvals
    • Downing NS, Shah ND, Neiman JH, Aminawung JA, Krumholz HM, Ross JS,. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 US Food and Drug Administration approvals. Trials. 2016; 17: 199.
    • (2016) Trials , vol.17 , pp. 199
    • Downing, N.S.1    Shah, N.D.2    Neiman, J.H.3    Aminawung, J.A.4    Krumholz, H.M.5    Ross, J.S.6
  • 22
  • 23
    • 85011581868 scopus 로고    scopus 로고
    • US Food and Drug Administration. Published. Accessed June 29, 2016
    • US Food and Drug Administration. Approval order: inspire upper airway stimulation. http://www.accessdata.fda.gov/cdrh-docs/pdf13/P130008A.pdf. Published 2014. Accessed June 29, 2016.
    • (2014) Approval Order: Inspire Upper Airway Stimulation
  • 25
    • 84939133213 scopus 로고    scopus 로고
    • Characteristics of clinical studies conducted over the total product life cycle of high-risk therapeutic medical devices receiving FDA premarket approval in 2010 and 2011
    • Rathi VK, Krumholz HM, Masoudi FA, Ross JS,. Characteristics of clinical studies conducted over the total product life cycle of high-risk therapeutic medical devices receiving FDA premarket approval in 2010 and 2011. JAMA. 2015; 314: 604-612.
    • (2015) JAMA , vol.314 , pp. 604-612
    • Rathi, V.K.1    Krumholz, H.M.2    Masoudi, F.A.3    Ross, J.S.4
  • 26
    • 85011618606 scopus 로고    scopus 로고
    • American Academy of Otolaryngology-Head and Neck Surgery. Published. Accessed June 29, 2016
    • American Academy of Otolaryngology-Head and Neck Surgery. Regent ENT clinical data registry. http://www.entnet.org/content/otoregistry. Published 2016. Accessed June 29, 2016.
    • (2016) Regent ENT Clinical Data Registry


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.